Tandem Diabetes Care (TNDM) Operating Income (2016 - 2025)
Historic Operating Income for Tandem Diabetes Care (TNDM) over the last 13 years, with Q3 2025 value amounting to -$22.9 million.
- Tandem Diabetes Care's Operating Income rose 1237.88% to -$22.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$196.1 million, marking a year-over-year decrease of 4679.99%. This contributed to the annual value of -$99.1 million for FY2024, which is 5749.82% up from last year.
- Tandem Diabetes Care's Operating Income amounted to -$22.9 million in Q3 2025, which was up 1237.88% from -$51.8 million recorded in Q2 2025.
- Tandem Diabetes Care's 5-year Operating Income high stood at $12.7 million for Q4 2021, and its period low was -$127.8 million during Q1 2023.
- In the last 5 years, Tandem Diabetes Care's Operating Income had a median value of -$26.1 million in 2024 and averaged -$31.5 million.
- Its Operating Income has fluctuated over the past 5 years, first skyrocketed by 86511.4% in 2021, then crashed by 73333.55% in 2023.
- Over the past 5 years, Tandem Diabetes Care's Operating Income (Quarter) stood at $12.7 million in 2021, then crashed by 239.56% to -$17.8 million in 2022, then crashed by 97.22% to -$35.1 million in 2023, then skyrocketed by 98.34% to -$581000.0 in 2024, then tumbled by 3835.11% to -$22.9 million in 2025.
- Its last three reported values are -$22.9 million in Q3 2025, -$51.8 million for Q2 2025, and -$120.9 million during Q1 2025.